The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Your company account is blocked and you cannot place orders. If you have questions, please contact your company administrator.
5-bromo-2-[(3-trifluoromethylphenyl)amino]benzoic acid ID: ALA259242
PubChem CID: 44457119
Max Phase: Preclinical
Molecular Formula: C14H9BrF3NO2
Molecular Weight: 360.13
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)c1cc(Br)ccc1Nc1cccc(C(F)(F)F)c1
Standard InChI: InChI=1S/C14H9BrF3NO2/c15-9-4-5-12(11(7-9)13(20)21)19-10-3-1-2-8(6-10)14(16,17)18/h1-7,19H,(H,20,21)
Standard InChI Key: WWTNJEXUBOVALJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
13.1444 -3.5125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1432 -4.3398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8581 -4.7527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5745 -4.3394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5716 -3.5088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8563 -3.0997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2846 -3.0936 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.0006 -3.5034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0003 -4.3261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7155 -4.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4294 -4.3206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4236 -3.4913 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7079 -3.0853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1351 -3.0736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8458 -2.6542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.5536 -3.7846 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.7163 -2.3628 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.8533 -2.2709 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5666 -1.8563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.1376 -1.8606 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.4284 -4.7518 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
13 8 1 0
1 2 2 0
12 14 1 0
5 7 1 0
14 15 1 0
3 4 2 0
14 16 1 0
7 8 1 0
14 17 1 0
8 9 2 0
4 5 1 0
18 19 1 0
18 20 2 0
6 18 1 0
9 10 1 0
2 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Calculated Properties Molecular Weight: 360.13Molecular Weight (Monoisotopic): 358.9769AlogP: 4.91#Rotatable Bonds: 3Polar Surface Area: 49.33Molecular Species: ACIDHBA: 2HBD: 2#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.71CX Basic pKa: ┄CX LogP: 6.02CX LogD: 2.72Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.82Np Likeness Score: -1.43
References 1. Van Antwerpen P, Prévost M, Zouaoui-Boudjeltia K, Babar S, Legssyer I, Moreau P, Moguilevsky N, Vanhaeverbeek M, Ducobu J, Nève J, Dufrasne F.. (2008) Conception of myeloperoxidase inhibitors derived from flufenamic acid by computational docking and structure modification., 16 (4): [PMID:18063373 ] [10.1016/j.bmc.2007.11.025 ] 2. Tidén, Anna-Karin AK and 16 more authors. 2011-10-28 2-thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation. [PMID:21880720 ] 3. Roth, Aaron and 9 more authors. 2014-11-15 Inhibition of myeloperoxidase: evaluation of 2H-indazoles and 1H-indazolones. [PMID:25438766 ]